← Back to Search

Procedure

Robotic Waterjet Treatment for Prostate Cancer

N/A

Recruiting

Research Sponsored by PROCEPT BioRobotics

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Prostate volume ≥ 30 ml

Clinical Stage ≤ T2c

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months post-treatment

Awards & highlights

Study Summary

This trial tests a robotic system to treat prostate cancer. Participants will be monitored for up to a year.

Who is the study for?

Men with localized prostate cancer who haven't had previous treatments for an enlarged prostate in the last year, have a prostate volume of at least 30 ml, PSA levels at or below 20 ng/ml, and are classified as Grade Group 1 or 2. Men with advanced disease like bone metastasis, lymph node involvement confirmed by biopsy/PET scan, extracapsular spread, seminal vesicle invasion or any other serious health risks are not eligible.Check my eligibility

What is being tested?

The trial is testing the AQUABEAM Robotic System's safety for treating localized prostate cancer. Participants will undergo this robotic waterjet treatment and be monitored through various assessments over a period of up to one year.See study design

What are the potential side effects?

While specific side effects aren't listed here, similar procedures may include risks such as discomfort at the treatment site, urinary issues like difficulty urinating or infection risk post-treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My prostate is larger than 30 ml.

Select...

My cancer is in an early stage and has not spread widely.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months post-treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months post-treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of participants who experience a serious device-related adverse event within 12 months following the study treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: AquablationExperimental Treatment1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

PROCEPT BioRoboticsLead Sponsor

12 Previous Clinical Trials

1,019 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available for this research experiment?

"This clinical trial, which was initially posted on October 1st 2023 and last modified on September 19th of the same year, is no longer recruiting participants. Nevertheless, there are still 1277 medical trials open to potential volunteers at this moment in time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System

2024. "PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06054867.

All > Prostate Cancer San Diego